Introduction: Allergic rhinitis, or allergic rhinosinusitis, is characterized by inflammation of the nasal mucosa leading to paroxysms of sneezing, rhinorrhea, and nasal obstruction, often accompanied by itching of the eyes, nose, and palate. The clinical manifestation recurs after each exposure to the initiating allergen. Methods: This research is descriptive type with a cross-sectional study was carried out at Dept. of ENT, BSMMU, Dhaka, Bangladesh from July 2022 to August 2023. Total 60 patients included in our study. The highest range of age in the 18-49 years. The sampling technique in this research was sequential (consecutive sampling). The type of data used is primary data including name, age, gender, symptoms of allergic rhinitis, clinical manifestations, questionnaire scores on allergic rhinitis. Results: From 60 patients, numbers of male and female in the subjects’ general characteristics were mostly women (55%) with the highest range of age in the 18-34 age group (36.6%), followed by 35-qwsa 49 age group (30%). A majority of the subjects were school/ college students (33.3%) and private employee (30%). In this study, the most sufferers were moderate to severe persistent allergic rhinitis, namely 47 people (78.3%), followed by mild intermittent 12 people (20%). Allergic shiner is the result of inspection of the most common signs of allergy on the face found in this study (83.3%), while allergic creases were only found in 2 respondents (3.3%). The most common symptoms are: nasal obstruction of 52 people (86.6%), followed by rhinorrhea with 46 people (76.6%). Most of the study subjects present with comorbidity (100%) with rhinosinusitis as the highest frequency (55%). Conclusion: This research is allergic rhinitis patients, in particular the Sub-Allergy Immunology at with the hope that the treatment management algorithm is appropriate and provides clinical improvement in both signs and symptoms of rhinitis patients.